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Introduction
The commonest cause of human deaths in most devel-
oped and developing countries is atherosclerosis, a
chronic progressive disease that affects large arteries,
including the coronary blood vessels (Rosamond et al.
2007). Atherosclerosis is a form of chronic inﬂammation
that arises because hyperlipidemia and modiﬁed lipopro-
teins cause accumulation of cholesterol-laden macrophag-
es and inﬂammatory cells below the endothelial lining of
the large arteries (Glass and Witztum 2001; Binder et al.
2002; Hansson 2005; Steinberg 2006). Other processes
accelerating atherosclerosis include naturally occurring
anti-endothelial antibodies (Binder et al. 2005), mechani-
cal stress in blood vessels such as high blood pressure
and turbulent ﬂow (Traub and Berk 1998; Escobar
2002); autoimmune diseases (Sherer and Shoenfeld 2006;
Soltesz et al. 2007); accumulation of advanced glycation
end-products arising from high blood glucose in diabet-
ics (Goldin et al. 2006), the ‘metabolic syndrome’ associ-
ated with high triglycerides and suppressed high density
lipoprotein (HDL) levels (Eckel et al. 2005; Meerarani
et al. 2006); genetic variations affecting the low density
lipoprotein (LDL) receptor (Horton et al. 2007); and,
chronic inﬂammation associated with gingivitis, arthritis,
obesity, or cigarette smoking (Haynes and Stanford 2003;
Libby and Ridker 2004; Gonzalez-Gay et al. 2006;
Fantuzzi and Mazzone 2007; Yanbaeva et al. 2007). Thus,
well-known risk factors for atherosclerosis include hyper-
cholesterolemia, diabetes, obesity, hypertension, cigarette
smoking, family history of heart disease and a sedentary
lifestyle.
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Abstract
Heart disease is common in both humans and chimpanzees, manifesting typi-
cally as sudden cardiac arrest or progressive heart failure. Surprisingly, although
chimpanzees are our closest evolutionary relatives, the major cause of heart dis-
ease is different in the two species. Histopathology data of affected chimpanzee
hearts from two primate centers, and analysis of literature indicate that sudden
death in chimpanzees (and in gorillas and orangutans) is commonly associated
with diffuse interstitial myocardial ﬁbrosis of unknown cause. In contrast, most
human heart disease results from coronary artery atherosclerosis, which
occludes myocardial blood supply, causing ischemic damage. The typical myo-
cardial infarction of humans due to coronary artery thrombosis is rare in these
apes, despite their human-like coronary-risk-prone blood lipid proﬁles. Instead,
chimpanzee ‘heart attacks’ are likely due to arrythmias triggered by myocardial
ﬁbrosis. Why do humans not often suffer from the ﬁbrotic heart disease so
common in our closest evolutionary cousins? Conversely, why do chimpanzees
not have the kind of heart disease so common in humans? The answers could
be of value to medical care, as well as to understanding human evolution. A
preliminary attempt is made to explore possibilities at the histological level,
with a focus on glycosylation changes.
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many anatomical locations, the most prominently
affected organ in humans is the heart. Coronary athero-
sclerosis frequently manifests as a ‘heart attack’, in
which the patient becomes suddenly ill with chest pain,
sweating and shortness of breath, resulting from
obstruction of a major coronary artery that provides
blood supply to the heart muscle (White and Chew
2008). Such acute coronary occlusion often results in
ischemic death of the cardiac muscle regions that are
perfused by the artery in question, and can even result
in sudden death (Davies and Thomas 1984; Farb et al.
1995; Virmani et al. 2001). If the patient survives, there
is a slow repair and remodeling process, wherein the
ischemic muscle is mostly replaced by scar tissue, as car-
diomyocytes cannot regenerate signiﬁcantly. Those who
survive an initial coronary occlusion often have recur-
rent coronary events and/or develop progressive heart
failure due to loss of cardiac muscle function and the
continued progression of the underlying disease process.
In other humans who do not suffer such an acute car-
diac event, the primary manifestation of atherosclerotic
coronary artery disease can be progressive heart failure,
due to the gradual loss of blood supply and ischemic
damage to the myocardium (Mosterd and Hoes 2007;
Boden 2008).
Chimpanzees are our closest evolutionary relatives,
with nearly 99% identity of many of our homologous
protein sequences (The Chimpanzee Sequencing, Analy-
sis Consortium, 2005; Varki and Nelson 2007; Varki
et al. 2008). Thus, at ﬁrst glance it is not surprising
that published data about chimpanzees cared for in cap-
tivity lists heart failure and/or sudden death due to
‘heart attacks’ as being among the commonest causes of
death (Schmidt 1978; Munson and Montali 1990;
Hubbard et al. 1991). However, closer examination of
the clinical and pathological ﬁndings indicates that the
mechanisms causing heart disease in humans and chim-
panzees are quite different. This remarkable and surpris-
ing difference is the subject of this article, in which we
present some new data, and also synthesize existing
reports on the subject. We also address the limited data
available on the other Hominids (‘Great Apes’) that
have been studied (Gorillas and Orangutans), showing
that they are more like chimpanzees than humans in
this respect. Overall, we conclude that rather than rep-
resenting a similarity, heart disease is an instance where
there are unexplained human-speciﬁc differences from
the other Hominids. Finally, we provide preliminary
evidence for differences in extracellular matrix and gly-
cosylation patterns of human and great ape myocar-
dium, which could potentially be relevant to
understanding this difference.
Materials and methods
Animals
The chimpanzees (Pan troglodytes) maintained at both the
Yerkes National Primate Research Center (YNPRC) and
the Primate Foundation of Arizona (PFA) were socially
housed in indoor/outdoor enclosures of various sizes and
conﬁgurations. They were fed low fat (<5%) commercial
primate diets from Purina Mills (Monkey Diet Jumbo
5037 at YNPRC; Fiber Plus 5049 and High Protein 5045
Monkey Diets at PFA), with daily fruit and vegetable
supplements.
Clinical data collection and analysis
Prior literature on the subject of heart disease in chim-
panzees and other great apes was surveyed (Gray et al.
1981; Cousins 1983; Hansen et al. 1984; McNamara et al.
1987; Munson and Montali 1990; Hubbard et al. 1991;
Schulman et al. 1995; Lowenstine 2003; Doane et al.
2006; Lammey et al. 2008, 2008; Seiler et al. 2008). The
medical records of all adult chimpanzees (>10 years of
age), cared for over many decades at the Yerkes National
Primate Center in Atlanta (1966–2008) and at the PFA
(1987–2007) were reviewed to determine the frequency of
major illnesses and causes of death. Records were
included in the ﬁnal summary only if a terminal necropsy
had been done to conﬁrm the likely cause of death.
Histological staining of myocardial tissue sections
Parafﬁn sections of myocardium were deparafﬁnized,
rehydrated, and stained to analyze morphology, using the
routine hematoxylin and eosin staining. To ensure com-
parability, sections from human and great ape hearts were
paired and stained on the same slide, whenever possible.
Duplicate slides were stained using the Masson’s tri-
chrome stain to detect collagen, following the manufac-
turer’s instructions. Other sets of slides were blocked for
endogenous biotin and overlaid with predetermined dilu-
tions of three different biotinylated lectins in Tris-
buffered saline with 0.5% Tween (TBST), containing
1m m calcium chloride, 1 mm magnesium chloride, and
1m m manganese chloride, or with secondary reagent
alone. After incubation in a humid chamber for 30 min,
unbound lectins were washed off using the same buffer.
Sections were then overlaid with alkaline phosphatase
labeled streptavidin (Jackson ImmunoResearch, West
Grove, PA) for 30 min in a humid chamber. After more
washes, bound lectins were detected using freshly made
alkaline phosphatase substrate Vector Blue (Vector labs,
Burlingame, CA, USA), and nuclei were counterstained
with nuclear fast red (Vector Labs).
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Heart disease is the commonest cause of death in recent
series of captive chimpanzees
Prior to the last two decades, infection was the common-
est cause of death in chimpanzees (see for example the
Yerkes experience from 1966 to 1991 shown in Table 1).
However, with improvements in infection control by vac-
cination and antibiotics, heart disease has now become
the commonest cause of death at all centers surveyed (see
Tables 1 and 2). Further analysis was focused on cases in
which sudden deaths and/or heart failure occurred with-
out any other obvious antecedent or precipitating illness.
Early reports on heart disease in chimpanzees and other
great apes
Although many series describing chimpanzee deaths in
captivity list heart disease as a major cause of death, sev-
eral of these reports also commented that gross coronary
atherosclerosis was not seen at necropsy (Munson and
Montali 1990; Hubbard et al. 1991; Lowenstine 2003).
These series as well as various case reports also mention
ﬁbrosis of the myocardium in gorillas, orangutans, and
chimpanzees (Gray et al. 1981; Cousins 1983; Hansen
et al. 1984; McNamara et al. 1987; Munson and Montali
1990; Schulman et al. 1995) (see Table 3 for a summary
of some examples). Meeting abstracts, nonpeer-reviewed
literature, and news reports also contain several examples
of unexplained sudden deaths of captive great apes, both
in primate centers and zoos.
High frequency of interstitial myocardial ﬁbrosis and
cardiomyopathy at necropsy in chimpanzees
A 2005 meeting in La Jolla (‘Understanding Great Apes
in the Genomic Era’) included a review of the experience
of the Yerkes Primate Center, concluding that extensive
myocardial ﬁbrosis was in fact a very common cause of
sudden death and heart failure in chimpanzees, particu-
larly among males. Presentation of these ﬁndings gener-
ated considerable interest and discussion, leading to
conﬁrmation at other institutions, including papers show-
ing a high frequency of cardiac anomalies in chimpanzees
such as arrhythmias (Doane et al. 2006) and myocardial
ﬁbrosis (Lammey et al. 2008, 2008; Seiler et al. 2008). In
these reports as well, a higher incidence of both patholo-
gies was observed in males than in females. While these
recent reports (see Table 3) did comment on human
heart disease, they did not draw the striking contrast with
regard to the different underlying pathological processes,
i.e., coronary atherosclerosis as the main mechanism in
humans, and myocardial ﬁbrosis in chimpanzees. While
different terms have been used to describe the latter
pathology, we hereafter refer to it as interstitial myocar-
dial ﬁbrosis (IMF).
Here we have returned to the originally reported Yerkes
series and combined it with experience from the PFA. A
total of 16 deaths out of 52 in animals 10 years or older
were attributed to heart disease in animals that died at
the Yerkes Primate Research Center between 1992 and
2005 and were carefully examined with regard to the his-
tological sections of affected hearts. This included nine
animals (eight male; one female) in which sudden unex-
pected death occurred and three animals in which acute
onset of severe illness (two male; one female) was noted.
Indeed, all these deaths were associated with this unusual
form of pathological IMF. While normal myocardium
from humans and from chimpanzees are histologically
quite similar (Fig. 1 uppermost panels), no human coun-
terpart was observed of the mild, moderate or extensive
IMF seen in chimpanzees (see Fig. 1 for an example of
extensive ﬁbrosis). The chimpanzee heart ﬁbrosis was
observed to be distributed haphazardly throughout the
cardiac muscle, with no predilection for areas immedi-
ately surrounding blood vessels, as can be seen in some
human hearts (Fig. 1). The ﬁbrosis could be more
Table 1. Primary causes of death in adult* Yerkes chimpanzees.
General category
1966–1991 1992–2008
n (%) n (%)
Meningitis 4 (11) –
Heart disease 4 (11) 21 (36)
Enterocolitis 6 (16) –
Pneumonia 2 (5) –
Renal disease 2 (5) 9 (16)
Trauma 1 (3) 7 (12)
Miscellaneous 19 (50) 21 (36)
38 58
*>10 years of age.
Table 2. Major causes of death in adult* chimpanzees in recent
times.
PFA
1992–2006
SNPRC
1982–2006
APF§
2001–2006
YNPRC–
1992–2008
Heart disease 1 (14%) 30 (35%) 13 (36%) 21 (36%)
Pneumonia 1 ns* – –
Renal disease 2 ns 9 9
Trauma – ns 3 7
Miscellaneous 4 57 11 21
Total 7 87 36 58
ns, not speciﬁed.
*>10 years of age; PFA colony mortality data; Seiler et al. (2008);
§Lammey et al. (2008); –YNPRC data from Table 1.
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collagen ﬁbers (see Fig. 1). Mild to moderate myocardial
ﬁbrosis was also seen in a number of chimpanzees that
died of other causes during the period from 1992 to 2005
at the Yerkes Center. In total, 14 males and four females
presented at necropsy with this type of diffuse IMF dur-
ing this period.
Notably, although mild to moderate atherosclerosis was
observed in the aorta and other major blood vessels in
some of the chimpanzee necropsies, no major blockages
of the coronary arteries were observed in any case (ath-
erosclerosis of the Circle of Willis in the brain blood sup-
ply was sometimes seen, associated with strokes). Figure 1
shows a typical patent coronary artery in a chimpanzee,
in contrast to the severely affected coronary arteries typi-
cally seen in humans. There were also no reports at nec-
ropsy of localized loss of myocardial perfusion in
chimpanzees, which would manifest as either segmental
regional pallor or localized myocardial necrosis.
Of course, while interesting and corroborated by similar
surveys in geographically distinct primate centers through-
out the United States, these ﬁndings are not without cave-
ats. The relatively small sample size, the retrospective
nature of necropsy data, and the inability to conduct con-
trolled studies of the effects of experimental perturbations
on IMF progression in great apes are notable examples.
Nonetheless, the differences between the human and great
ape cardiac pathologies are quite striking.
Rarity of chimpanzee-like IMF pathology in humans
The cardiac pathology described above for chimpanzees is
in striking contrast to that seen in humans following a
coronary occlusive event, where the pathological features
of the myocardium are quite distinct, and major athero-
thrombotic occlusions of the coronary arteries are com-
mon. In fact, according to the literature, evidence of
coronary thrombosis or plaque disruption can be found
in up to 70% of postmortem cases of sudden death
(Davies and Thomas 1984; Farb et al. 1995; Virmani et al.
2001). In contrast, while limited or focal cardiac ﬁbrosis
can be seen in humans (especially in patients with
chronic hypertension or diabetes) (Diez 2007; Caglayan
et al. 2008), there is no well-recognized common human
pathological counterpart of the diffuse IMF seen in the
great ape population.
Association of myocardial ﬁbrosis with sudden death or
congestive heart failure in chimpanzees
In the case of humans with sudden death following a cor-
onary occlusion, the pathological mechanisms involved
Table 3. Examples of prior publications describing unexplained myocardial ﬁbrosis in chimpanzees and other great apes.
Reference Cases Total Notes
Hansen et al. (1984) 1 1 Case study of a 26-year-old male chimpanzee with myocardial ﬁbrosis.
Munson and Montali (1990) 1 1 Review of medical and pathology records of great apes at the National
Zoological Park. One chimpanzee of unspeciﬁed age was examined, and
reported to have cardiac ﬁbrosis and amyloidosis. Two orangutans also
reported to have cardiac ﬁbrosis.
Hubbard et al. (1991) 6 33 Review of chimpanzee medical records between 1981 and 1989 revealed
6 deaths due to myocardial disease. All had similar lesions including
lymphocytic myocarditis, myocardial ﬁbrosis, mineralization and necrosis.
Schulman et al. (1995) 11 19 A retrospective study describing ﬁbrosing cardiomyopathy in 11 male captive
lowland gorillas - out of a cohort of 16 male and 3 female individuals ranging
from 9–38 years of age who died of various causes, including 7 sudden deaths.
Doane et al. (2006) 29 36 Sudden cardiac death was leading cause of death. All such animals had
interstitial myocardial ﬁbrosis.
Lammey et al. (2008) 12 13 12 of 13 animals that died of sudden cardiac death had myocardial ﬁbrosis.
This is a subset of the animals examined in Lammey at al, (Lammey et al. 2008),
below.
Lammey et al. (2008) 29 36 Sudden cardiac death (SCD) in 13 (11 male and 2 female) chimpanzees was
leading cause of death. Cardiac arrhythmias (ventricular ectopy) seen in 15
(12 male and 3 female). Histologic examination showed IMF in 29 (81%).
Systemic hypertension noted only in 3 cases. No other causes of IMF noted.
Seiler et al. (2008) 50 87 Prevalence of heart disease in chimpanzees was 68% and prevalence of IMF was
51%. Prevalence at death was higher in males (60%) than in females (29%).
Heart disease was primary cause of death in 35%. No evidence that diet,
environment, viral agents, experimental use or disease exposure contributed
to IMF in chimpanzees.
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with resulting loss of functions and/or generation of
abnormal cardiac rhythms (arrhythmias) (White and
Chew 2008). While there is a strong association of myo-
cardial ﬁbrosis with sudden deaths in chimpanzees (many
with no obvious antecedent illness), the pathophysiologi-
cal mechanisms leading to death are less clear. Based on a
recent report of a high frequency of electrocardiographic
abnormalities in chimpanzees (Doane et al. 2006), malig-
nant arrythmias are the most likely precipitating event. In
contrast, in a series of 270 humans presenting with sud-
den cardiac death, only six showed evidence of IMF-like
features (John et al. 2004). Thus, sudden deaths of car-
diac etiology appear to arise predominantly from different
pathological processes between humans and chimpanzees,
despite the loose application of the term ‘heart attack’ to
both types of events.
Progressive congestive heart failure with or without any
acute terminal cardiac event is another common cause of
death in chimpanzees (six in this series at Yerkes) and in
humans. Again, while the commonest cause of such pro-
gressive congestive heart failure in humans is ischemic
heart disease due to atherosclerotic coronary disease
(Rosamond et al. 2007), the associated pathology in
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Chimpanzee
Figure 1 Examples of histological com-
parisons of human and chimpanzee
hearts and coronary blood vessels. Top
panels: Hematoxylin and eosin stains of
normal myocardium sections from
humans and chimpanzees look very sim-
ilar. Upper middle panels: Example of
ﬁbrosis immediately surrounding blood
vessels, as seen in some human hearts,
and example of extensive interstitial
myocardial ﬁbrosis in chimpanzee heart.
Lower middle panels: Collagen ﬁbrosis is
more clearly seen in Masson’s trichrome
stain. Bottom panels: Atherosclerotic
coronary artery typically seen in humans
(note the subendothelial plaques), com-
pared with a typical uninvolved coronary
artery in a chimpanzee, as seen in Mas-
son’s Trichrome stain.
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cardiomyopathy. We of course recognize that no rigorous
study has or can be performed in which the environmen-
tal and nutritional variables of the captive chimpanzee are
imposed on humans. Thus, it is difﬁcult to argue
conclusively that humans would never get signiﬁcant IMF
under the identical conditions. We also recognize that the
captive lifestyle includes a diet low in cholesterol and a
major portion of calories accounted for by fruits and
vegetables, factors that could reduce risk the atherosclero-
sis. However, as discussed below, great apes actually
appear to have a proatherogenic lipid proﬁle.
Similar IMF pathology also occurs in the other great ape
deaths with cardiac disease
In addition to the literature on IMF in chimpanzees
(Hansen et al. 1984; Munson and Montali 1990; Hubbard
et al. 1991; Lowenstine 2003; Lammey et al. 2008, 2008;
Seiler et al. 2008), there are reports of sudden deaths or
heart failure in the other closely related hominids (gorillas
and orangutans) attributed to cardiac events, again associ-
ated with similar descriptions of myocardial ﬁbrosis (Gray
et al. 1981; Cousins 1983; Hansen et al. 1984; McNamara
et al. 1987; Munson and Montali 1990; Schulman et al.
1995; Lowenstine 2003). Such reports tend to emphasize
the similarity of chimpanzees and other great apes to
humans, by noting that cardiovascular events are a major
cause of death in all of these hominids. However, most
also acknowledge the lack of severe atherosclerosis in
most of these apes and the rarity of coronary occlusive
disease. Indeed, a search of the extant literature revealed
only rare instances of acute coronary thrombosis in chim-
panzees and gorillas (Manning 1942; Vastesaeger et al.
1975; Blaton and Peeters 1976; Gray et al. 1981), typically
under dietary or blood lipid circumstances that would
have been expected to maximize the risk of severe athero-
sclerosis in humans.
Great apes often have proatherogenic blood lipid proﬁles
It is well-recognized that spontaneous atherosclerosis does
not occur in rodents, which are the evolutionary clade
closest to primates. Even in genetically manipulated mod-
els with very high cholesterol levels, it is difﬁcult to show
the severe atherosclerotic features that are common in
humans (e.g., occlusive thrombosis). Thus, although
genetically modiﬁed apoe)/) mice can suffer from myo-
cardial infarcts, the frequency is rare (Calara et al. 2001).
Watanabe heritable hyperlipidemic rabbits can also
develop spontaneous myocardial infarcts, but these ani-
mals are genetically modiﬁed, and still do not often show
coronary plaque rupture and thrombosis, as seen in
humans (Shiomi et al. 2003). This difﬁculty in inducing
advanced lesions in rodent and rabbit models is in stark
contrast to the prevalence of severe atherosclerosis in
humans, which occurs even in some individuals with
mildly elevated LDL levels and no other obvious risk fac-
tors (Vasan et al. 2005). Indeed, despite statin treatment
of their hypercholesterolemia 70% of such patients still
have adverse cardiovascular events (Steinberg 2008).
The clinical manifestations of atherosclerosis also tend
to be much commoner in humans than in nonhuman
primates. While captive great apes have a relatively
healthy diet from the perspective of atherosclerotic risk
(low in cholesterol and saturated fat), this is not reﬂected
in their serum lipid proﬁles. At the Yerkes Primate Cen-
ter, a mean total cholesterol level of 211.13 ± 38.85 mg/
dL was found in a population of 106 male captive chim-
panzees over their 50-plus-year lifespan (Herndon and
Tigges 2001). Similar ranges were noted at PFA (Howell
et al. 2003), and at another center (Hainsey et al. 1993).
Figure 2 shows a age-based longitudinal comparison
between cholesterol levels in normal humans participating
in the Framingham Heart Study (Abbott et al. 1983) and
captive chimpanzees at the Yerkes Primate Center (Hern-
don and Tigges 2001). Plotting total serum cholesterol
(mg/dL) as a function of age (decade of life) reveals two
striking observations. First, we can see that the mean total
serum cholesterol in this captive chimpanzee population
is well above the mean in the human population, at every
decade of life, in both males and females (Fig. 2). Second
and most intriguingly, we see that unlike the case in
humans, captive chimpanzees have high serum cholesterol
levels even in the early decades of life (Fig. 2). Thus, the
chimpanzee vasculature is exposed to high cholesterol lev-
els throughout adolescence and adulthood. Indeed the
levels in very young chimpanzees fall into a high enough
range wherein pharmacological statin therapy would now
be seriously considered in children (Daniels and Greer
2008).
Furthermore, evidence also indicates that chimpanzee
serum cholesterol proﬁles have similar LDL and HDL
components as humans. For instance, LDL cholesterol
levels of captive chimpanzees (171 ± 16 mg/dL, n =4 )
were found to be well above matched human levels
(108 ± 2 mg/dL, n = 5) and already in a range compara-
ble to the majority of at-risk humans (Vastesaeger et al.
1975; Blaton and Peeters 1976). Chimpanzee LDL choles-
terol can be further increased experimentally by athero-
genic diets (Vastesaeger et al. 1975; Blaton and Peeters
1976; Srinivasan et al. 1976). This augmentation in
plasma cholesterol can be attributed to an increase in
LDL levels with a concomitant suppression of HDL levels
(Srinivasan et al. 1976), similar to that seen in hypercho-
lesterolemic humans. Thus, many chimpanzees have
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atherogenic and requiring treatment in humans.
Additionally, chimpanzees and all other great apes are
homozygous for the ancestral APOE4 allele (Hanlon and
Rubinsztein 1995; Hacia et al. 1999), a well-known risk
factor for severe atherosclerosis in humans (Eichner et al.
1993; Ilveskoski et al. 1999; Altenburg et al. 2007). Fur-
thermore, chimpanzees have high levels of lipoprotein-
associated phospholipase A(2) or LP(a) (Doucet et al.
1994; Huby et al. 2001), another independent cardiovas-
cular risk marker (Corson et al. 2008). Despite hypercho-
lesterolemia, high LP(a) levels and having the high-risk
APOE4 allele, no deaths by myocardial infarction have
been cataloged in the autopsy records of chimpanzees at
major US primate centers. Thus, unlike the case with
humans (Steinberg 2006), serum lipid proﬁles in great
apes do not seem to correlate with risk, nor provide an
explanation for the rarity of coronary artery disease. Of
course, detailed studies of other aspects of great ape lipid
proﬁles (e.g., HDL levels, HDL/LDL ratios, apo B/apo A-I
ratios) (Fernandez and Webb 2008) need to be studied,
to ascertain if there are other explanations.
Two mysteries to be solved
When taken together, the data suggest that there are two
independent mysteries to be solved. First, why do humans
not suffer from a high frequency of diffuse IMF similar to
that seen in evolutionarily related great apes? Is this due
to speciﬁc evolutionary genetic changes in the human
lineage that protects us from this disease process? Con-
versely, could it be related to some as yet unknown expo-
sure of apes to some pathogenic agent (toxin or virus) in
captivity? In this regard, it would be very interesting to
know if such myocardial ﬁbrosis occurs in the great apes
in the wild. The second mystery is why the great apes do
not often develop the severe forms of atherosclerosis and
coronary thrombosis characteristic of humans. Chimpan-
zees in captivity have a life-span long enough to be per-
missive of atherogenesis, and as discussed, many have
lipid proﬁle levels that would be considered a signiﬁcant
risk for coronary cardiovascular disease in humans. Cap-
tive great apes are also not free of other human coronary
risk factors such as hypertension exacerbated by high salt
intake (Denton et al. 1995; Elliott et al. 2007) and obesity.
They are also relatively sedentary when compared to their
wild counterparts, a lifestyle similar to modern humans.
However, despite such similarities, there is relative lack of
severe atherosclerotic lesions in chimpanzees compared to
humans, and myocardial infarctions in great apes are very
rare.
Thus, it appears likely that there are other genetic and/
or environmental factors that predispose humans to
severe atherosclerosis. One possibility we have recently
suggested is an immune response to the metabolic incor-
poration and accumulation of a dietary nonhuman sialic
acid N-glycolylneuraminic acid (Neu5Gc) in large blood
vessel endothelia, in the face of an ongoing antibody
immune response against this foreign molecule (Nguyen
et al. 2005; Padler-Karavani et al. 2008; Varki 2008). We
hypothesize that this combination generates additional
chronic inﬂammation in human blood vessels, accelerat-
ing the atherosclerotic process. Another contributing fac-
tor could be the hyper-reactive phenotype of human T
cells, relative to those of chimpanzees (Nguyen et al.
2006; Varki 2008), potentially aggravating the chronic
inﬂammation seen in atherosclerotic plaques. We are
currently working towards a mouse model that is
Figure 2 Longitudinal age-based comparison of total serum choles-
terol in human and captive chimpanzee populations. Chimpanzee and
human cholesterol levels were taken from two independent, original
articles and plotted here, on the same axis, for comparison. Total
serum cholesterol data from both publications was grouped by sex
and age in decades. Human data were acquired from 6757 partici-
pants in the Framingham Heart Study, aged 15–79 years (Abbott
et al. 1983). Chimpanzee data were acquired from 252 chimpanzees,
aged 0–60, living in captivity at the Yerkes Primate Center (Herndon
and Tigges 2001). Data are plotted as mean ± 95% CI. Error bars are
not shown for the oldest chimps (5th decade in males, n = 1; 6th
decade in females, n = 3) due to the very small sample size. Note that
the total serum cholesterol (Y axis) starts at 100 mg/dL, to make the
differences clearer.
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However, the resistance of the mouse to spontaneous ath-
erosclerosis is a signiﬁcant barrier, and standard mouse
models of atherosclerosis require major perturbations of
cholesterol homeostasis and inﬂammation to engender
disease progression. Thus, studies in mice may or may
not be completely relevant to the differences of human
and chimpanzee pathology.
In search of a mechanism for IMF in great apes
We and others are currently unable to identify any speciﬁc
marker or measurement that could predict the risk of the
IMF cardiac disease that is common in chimpanzees, and
the underlying etiology that remains unknown. As an ini-
tial attempt to search for mechanisms, we compared
apparently normal-appearing myocardial sections from
humans and great apes using histochemical methods.
Parafﬁn sections of hearts from humans, chimpanzees,
gorillas, and orangutans were stained using the Masson-
Trichrome stain for collagen. As shown in Fig. 3, other-
wise normal heart sections from all three great apes
showed collagen bundles that appeared to divide the heart
muscle along the planes where the larger blood vessels
were situated. This pattern was not observed in the human
heart sections. The sections of heart muscle were from
cases not related to sudden deaths or heart failure,
although some of the human cases had a clinical history of
hypertension. Thus, even in otherwise healthy-appearing
great ape hearts there is a pattern of increased collagen in
the heart muscle, which is visible in the connective tissue
surrounding blood vessels and extends for some distances,
conferring an appearance of heart muscle in ‘bundles’.
This was observed also in a chimpanzee as young as
13 years old. It remains uncertain whether this represents
the normal condition of great apes, or incipient IMF.
Given the known differences in sialic acid biology
between humans and great apes (Varki 2008), we also
stained normal-appearing myocardial sections from
humans and apes with two lectins that bind sialic acids:
Sambucus nigra agglutinin (SNA) which recognizes termi-
nal Siaa2-6Galb1-4GlcNAcb- units on N-linked glycan
chains of glycoproteins, and Maackia Amurensis hemag-
glutinin (MAH), which recognizes Siaa2-3Gal termini on
various glycoconjugates (Martin et al. 2002; Varki and
Varki 2007). Both SNA and MAH strongly stained large
areas of heart sections from chimpanzees, gorillas and
orangutans, with MAH staining again showing evidence
of encircling ‘bundles’ that were not seen in human heart
sections (Fig. 4). These differences with SNA and MAH
lectin staining imply that terminal sialic acids are much
denser in the great ape heart. As terminal sialic acids are
often the target for viral pathogens (Varki and Varki
2007; Varki 2008), one can speculate that this may render
Human Chimpanzee
Gorilla Orangutan
Figure 3 Masson’s trichrome staining
for collagen in histologically normal-
appearing myocardial tissue sections
from humans and great apes. ·40
magniﬁcation. Scale bar represents 50
microns. Examples are shown of the
staining patterns in human and great
apes. The results shown are typical
of that seen with six human, six
chimpanzee, three gorilla, and four
orangutan samples.
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gen that binds sialic acids and initiates the ﬁbrotic pro-
cess. In this regard, occasional lymphocytic inﬁltrates can
occasionally surround the scarred areas, suggesting the
possibility of precedent viral myocarditis in some cases
(data not shown).
We also used the Ulex Europaeus agglutinin (UEA) lec-
tin, which recognizes terminal fucose residues in the
sequence Fuca1-2Galb1-4GlcNAcb-, and is very useful for
the identiﬁcation of blood vessels in human sections.
Remarkably, we found that while the UEA lectin stained
small coronary vessels as well as numerous capillary blood
vessels in human hearts, sections from all three apes
showed only staining of the larger vessels, with many
fewer intermyocardial ﬁber capillaries. Endurance running
is thought to be a derived capability of the genus Homo
(Bramble and Lieberman 2004). Thus, the apparently lar-
ger number of human intermyocardial capillaries identi-
ﬁed by the UEA lectin may imply a richer myocardial
blood supply in humans, and this may possibly reduce
the risk of developing myocardial ﬁbrosis. Alternatively,
such differences in glycosylation could by themselves alter
interactions amongst extracellular matrix components,
perhaps predisposing the apes to the ﬁbrotic process.
These and other possibilities deserve further investigation.
A truly prospective, longitudinal study of captive chim-
panzee cohorts using noninvasive techniques such as
echocardiography during the natural course of an ani-
mal’s lifetime would also be an improvement over the
retrospective data currently available for analyses like
ours. Regardless of the model or the study, answers to
these questions would be of value not only to the medical
care of both humans and other hominids, but also to our
understanding of unique features of human evolution.
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